{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:441203",
      "entity_text" : "cisplatin",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03312",
      "entity_text" : "siR-beta-catenin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Furthermore, treatment with both siR-beta-catenin and cisplatin further decreased the migratory and invasive capabilities of the T47D and MCF-7 cells, indicating that downregulation of beta-catenin may enhance the antitumor effect of cisplatin (XREF_FIG).",
  "reading_complete" : "2020-08-02T16:16:31Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T16:15:29Z",
  "trigger" : "decreased",
  "evidence" : [ "siR-beta-catenin and cisplatin further decreased the migratory and invasive capabilities of the T47D and MCF-7 cells, indicating that downregulation of beta-catenin may enhance the antitumor effect of cisplatin" ],
  "pmc_id" : "7169654",
  "score" : 0
}